<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20031101//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">3098833</article-id><article-id pub-id-type="pmid">21625478</article-id><article-id pub-id-type="publisher-id">PONE-D-10-05816</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0019825</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biology</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Drug Discovery</subject></subj-group></subj-group><subj-group><subject>Biotechnology</subject><subj-group><subject>Drug Discovery</subject></subj-group></subj-group><subj-group><subject>Microbiology</subject><subj-group><subject>Virology</subject><subj-group><subject>Antivirals</subject><subject>Viral Enzymes</subject><subject>Viral Replication</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Chemistry</subject><subj-group><subject>Medicinal Chemistry</subject></subj-group></subj-group></article-categories><title-group><article-title>Anti-Influenza Activity of Marchantins, Macrocyclic Bisbibenzyls Contained in Liverworts</article-title><alt-title alt-title-type="running-head">Anti-Influenza Activity of Cyclic Bisbibenzyls</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Iwai</surname><given-names>Yuma</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Murakami</surname><given-names>Kouki</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Gomi</surname><given-names>Yasuyuki</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Hashimoto</surname><given-names>Toshihiro</given-names></name><xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Asakawa</surname><given-names>Yoshinori</given-names></name><xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Okuno</surname><given-names>Yoshinobu</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ishikawa</surname><given-names>Toyokazu</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Hatakeyama</surname><given-names>Dai</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Echigo</surname><given-names>Noriko</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Kuzuhara</surname><given-names>Takashi</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="corresp" rid="cor1">
<sup>&#x0002a;</sup>
</xref></contrib></contrib-group><aff id="aff1">
<label>1</label>
<addr-line>Laboratory of Biochemistry, Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Yamashiro-cho, Tokushima, Japan</addr-line>
</aff><aff id="aff2">
<label>2</label>
<addr-line>Research group, Research and Production Technology Division, Kanonji Institute, The Research Foundation for Microbial Diseases of Osaka University, Kanonji, Kagawa, Japan</addr-line>
</aff><aff id="aff3">
<label>3</label>
<addr-line>Laboratory of Pharmacognosy, Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Yamashiro-cho, Tokushima, Japan</addr-line>
</aff><aff id="aff4">
<label>4</label>
<addr-line>Laboratory of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Yamashiro-cho, Tokushima, Japan</addr-line>
</aff><contrib-group><contrib contrib-type="editor"><name><surname>Digard</surname><given-names>Paul</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">University of Cambridge, United Kingdom</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>kuzuhara@ph.bunri-u.ac.jp</email></corresp><fn fn-type="con"><p>Conceived and designed the experiments: TK. Performed the experiments: YI KM YG YO TI. Analyzed the data: NE DH TK. Contributed reagents/materials/analysis tools: TH YA. Wrote the paper: TK. Purified the phytochemicals: TH YA. Performed the PA endonuclease assay: YI NE DH TK. Performed the anti-influenza assay: KM YG OY IT. Devised the research plan, performed the docking simulation analysis: TK.</p></fn></author-notes><pub-date pub-type="collection"><year>2011</year></pub-date><pub-date pub-type="epub"><day>20</day><month>5</month><year>2011</year></pub-date><volume>6</volume><issue>5</issue><elocation-id>e19825</elocation-id><history><date date-type="received"><day>3</day><month>12</month><year>2010</year></date><date date-type="accepted"><day>18</day><month>4</month><year>2011</year></date></history><permissions><copyright-statement>Iwai et al.</copyright-statement><copyright-year>2011</copyright-year><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p></license></permissions><abstract><p>The H1N1 influenza A virus of swine-origin caused pandemics throughout the world in 2009 and the highly pathogenic H5N1 avian influenza virus has also caused epidemics in Southeast Asia in recent years. The threat of influenza A thus remains a serious global health issue and novel drugs that target these viruses are highly desirable. Influenza A possesses an endonuclease within its RNA polymerase which comprises PA, PB1 and PB2 subunits. To identify potential new anti-influenza compounds in our current study, we screened 33 different types of phytochemicals using a PA endonuclease inhibition assay <italic>in vitro</italic> and an anti-influenza A virus assay. The marchantins are macrocyclic bisbibenzyls found in liverworts, and plagiochin A and perrottetin F are marchantin-related phytochemicals. We found from our screen that marchantin A, B, E, plagiochin A and perrottetin F inhibit influenza PA endonuclease activity <italic>in vitro</italic>. These compounds have a 3,4-dihydroxyphenethyl group in common, indicating the importance of this moiety for the inhibition of PA endonuclease. Docking simulations of marchantin E with PA endonuclease suggest a putative &#x0201c;fitting and chelating model&#x0201d; as the mechanism underlying PA endonuclease inhibition. The docking amino acids are well conserved between influenza A and B. In a cultured cell system, marchantin E was further found to inhibit the growth of both H3N2 and H1N1 influenza A viruses, and marchantin A, E and perrotein F showed inhibitory properties towards the growth of influenza B. These marchantins also decreased the viral infectivity titer, with marchantin E showing the strongest activity in this assay. We additionally identified a chemical group that is conserved among different anti-influenza chemicals including marchantins, green tea catechins and dihydroxy phenethylphenylphthalimides. Our present results indicate that marchantins are candidate anti-influenza drugs and demonstrate the utility of the PA endonuclease assay in the screening of phytochemicals for anti-influenza characteristics.</p></abstract><counts><page-count count="11"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>An influenza A pandemic in 1918, known as the Spanish flu, caused 50 million deaths worldwide <xref rid="pone.0019825-Taubenberger1" ref-type="bibr">[1]</xref>&#x02013;<xref rid="pone.0019825-Horimoto1" ref-type="bibr">[3]</xref>. More recently, the avian H5N1 influenza A virus, which is highly pathogenic to humans, caused epidemics in Southeast Asia <xref rid="pone.0019825-Hatta1" ref-type="bibr">[4]</xref> and a new strain (Pandemic (H1N1) 2009) that emerged from pigs into humans caused a further pandemic in 2009 <xref rid="pone.0019825-Itoh1" ref-type="bibr">[5]</xref>, <xref rid="pone.0019825-Neumann1" ref-type="bibr">[6]</xref>. Strategies are thus needed to prevent future expansions of these viruses which remain a serious global health issue. Although neuraminidase inhibitors such as oseltamivir are widely used as anti-influenza drugs <xref rid="pone.0019825-DeClercq1" ref-type="bibr">[7]</xref>, <xref rid="pone.0019825-Hayden1" ref-type="bibr">[8]</xref>, some side effects of these agents and also the emergence of viral strains that are resistant to these agents have now been reported <xref rid="pone.0019825-Reece1" ref-type="bibr">[9]</xref>&#x02013;<xref rid="pone.0019825-Izumi1" ref-type="bibr">[11]</xref>. For the future prevention and control of influenza outbreaks, it will therefore be critical to develop novel drugs that are not based on neuraminidase inhibition.</p><p>The influenza A genome consists of segmented single stranded RNA (-) and its transcription and replication require the activity of a highly conserved RNA-dependent RNA polymerase <xref rid="pone.0019825-Honda1" ref-type="bibr">[12]</xref>&#x02013;<xref rid="pone.0019825-Kuzuhara1" ref-type="bibr">[14]</xref>. The influenza A RNA-dependent RNA polymerase is composed of three subunits, PA, PB1 and PB2, and synthesizes viral mRNAs using short capped primers derived from host cellular mRNAs that are cleaved by the viral endonuclease <xref rid="pone.0019825-Honda1" ref-type="bibr">[12]</xref>, <xref rid="pone.0019825-Honda2" ref-type="bibr">[13]</xref>. Yuan <italic>et al</italic>. and Dias <italic>et al</italic>. have shown previously that the N-terminal domain of the PA subunit contains a typical endonuclease active site and also harbors RNA/DNA endonuclease activity <xref rid="pone.0019825-Yuan1" ref-type="bibr">[15]</xref>&#x02013;<xref rid="pone.0019825-Kuzuhara2" ref-type="bibr">[17]</xref>. This domain is essential for viral growth and we speculated that it would be a highly effective target domain to which novel anti-influenza A drugs would bind.</p><p>The Marchantiophyta liverworts and several other types produce a large number of various lipophilic terpenoids, sesqui- and diterpenoids, phenolics <xref rid="pone.0019825-Asakawa1" ref-type="bibr">[18]</xref>&#x02013;<xref rid="pone.0019825-Harinantenaina1" ref-type="bibr">[28]</xref>, bibenzyls and bisbibenzyls <xref rid="pone.0019825-Asakawa4" ref-type="bibr">[21]</xref>&#x02013;<xref rid="pone.0019825-Harinantenaina1" ref-type="bibr">[28]</xref>. Marchantin (<xref ref-type="fig" rid="pone-0019825-g001">Fig. 1</xref>), a unique macrocyclic structure denoted as a cyclic bisbibenzyl, is a phytochemical found in several liverworts. The yield of marchantin A (MA) is extremely high (a 100&#x02013;120 gram quantity can be obtained from 2 kg of dried material), for the Japanese <italic>Marchantia poleacea</italic> var. <italic>diptera</italic>. Marchantins A (MA), B (MB), C (MC) and E (ME) and isomarchantin C (IMC) from <italic>Marchantia polymorpha</italic> and <italic>M. paleacea</italic>, riccarrdin A (RA) from <italic>Riccardia multifida</italic>, ptychantol A (PtA) from <italic>Ptychanthus striatus</italic>, plagiochin A (PlA) from <italic>Plagiochila fruticosa</italic>, all of which are marchantin-like phytochemicals, have one or two diaryl ether or biphenyl bonds (<xref ref-type="fig" rid="pone-0019825-g001">Fig. 1</xref>). The bisbibenzyl, perrottetin F (PeF), isolated from <italic>Lunularia cruciata</italic> is also similar to marchantin but is not cyclic (<xref ref-type="fig" rid="pone-0019825-g001">Fig. 1</xref>) <xref rid="pone.0019825-Asakawa1" ref-type="bibr">[18]</xref>&#x02013;<xref rid="pone.0019825-Asakawa6" ref-type="bibr">[23]</xref>. These compounds have shown interesting biological activities in the past such as cytotoxicity, 5-lipoxygenase inhibitory activity, inhibitory activity against NO production stimulated by lipopolysaccharide (LPS), antimicrobial activity, antitumor activity, and farnesoid X receptor (FXR)-activating activity, among others <xref rid="pone.0019825-Asakawa7" ref-type="bibr">[24]</xref>, <xref rid="pone.0019825-Suzuki1" ref-type="bibr">[25]</xref>.</p><fig id="pone-0019825-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0019825.g001</object-id><label>Figure 1</label><caption><title>Chemical structures of the phytochemicals tested in this study.</title><p>Diverse chemical structures of the phytochemicals screened in this study for their anti-influenza A activities. The sources for these structures are described in the materials and methods.</p></caption><graphic xlink:href="pone.0019825.g001"/></fig><p>In our current study, we screened 33 different phytochemicals using PA endonuclease <italic>in vitro</italic> and then examined the anti-influenza activities of these selected compounds. Marchantin and other phytochemicals (<xref ref-type="fig" rid="pone-0019825-g001">Fig. 1</xref>) were purified as previously described <xref rid="pone.0019825-Asakawa1" ref-type="bibr">[18]</xref>&#x02013;<xref rid="pone.0019825-Harinantenaina1" ref-type="bibr">[28]</xref>. We performed initial <italic>in vitro</italic> screenings for the inhibition of PA endonuclease activity. After this <italic>in vitro</italic> selection, we performed an anti-virus assay. We found from these analyses that marchantins and related chemicals inhibit PA endonuclease activity, and exert anti-influenza activity in cultured cells and in focus formation assays.</p></sec><sec id="s2"><title>Results</title><sec id="s2a"><title>Inhibition of PA endonuclease by marchantins</title><p>We tested 33 phytochemicals in a PA endonuclease-inhibition assay, as shown in <xref ref-type="fig" rid="pone-0019825-g001">Figure 1</xref>, using the recombinant PA endonuclease domain protein. In this assay, we incubated 0.1 &#x000b5;M of recombinant PA endonuclease domain with both 1 or 10 &#x000b5;M of each phytochemical. The PA endonuclease domain digests circular single stranded DNA <italic>in vitro</italic> (<xref ref-type="fig" rid="pone-0019825-g002">Fig. 2</xref>, lanes 1 &#x00026; 2) <xref rid="pone.0019825-Dias1" ref-type="bibr">[16]</xref>, <xref rid="pone.0019825-Iwai1" ref-type="bibr">[29]</xref> and we examined whether any of the phytochemicals in our panel could inhibit this activity. Only marchantin A (MA), B (MB), E (ME) and the marchantin-related chemicals, perrottetin F (PeF) and plagiochin A (PlA), showed any inhibitory activity at a 10 &#x000b5;M concentration (<xref ref-type="fig" rid="pone-0019825-g002">Fig. 2</xref>, lanes 3, 7, 15, 17 &#x00026; 21). This is the first evidence that the phytochemicals derived from the liverwort plant can inhibit the influenza A endonuclease. Each of the five inhibitory compounds also contain a dihydroxyphenethyl group (<xref ref-type="fig" rid="pone-0019825-g001">Fig. 1</xref>), which is absent from the other chemicals in the study panel (<xref ref-type="fig" rid="pone-0019825-g001">Fig. 1</xref>), thus suggesting its importance for PA endonuclease inhibition.</p><fig id="pone-0019825-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0019825.g002</object-id><label>Figure 2</label><caption><title>Screening of anti-influenza phytochemicals using a PA endonuclease-inhibition assay.</title><p>Screening of phytochemicals for anti-influenza A activity using a PA endonuclease assay. The effects of the various phytochemicals upon the endonuclease activity of the PA N-terminal domain of the influenza A RNA polymerase were tested. The recombinant PA N-terminal domain protein was added to each reaction at 0.35 &#x000b5;g/ 100 &#x000b5;l. A zero control (no PA domain added) was also assayed. Phytochemicals were added at a 1 or 10 &#x000b5;M dose and M13mp18 was used as the substrate.</p></caption><graphic xlink:href="pone.0019825.g002"/></fig></sec><sec id="s2b"><title>Docking simulation for marchantin with the influenza PA endonuclease domain</title><p>To further investigate how marchantin and its related chemicals inhibit PA endonuclease activity and why the dihydroxyphenethyl group is important for this function, we performed <italic>in silico</italic> docking simulation analysis of marchantin E with PA endonuclease using tertiary structure information. The tertiary structure of PA endonuclease has already been resolved <xref rid="pone.0019825-Zhao1" ref-type="bibr">[30]</xref> and the tertiary structure and flexibility of marchantin E was determined in our present study using the MOE program <xref rid="pone.0019825-Morris1" ref-type="bibr">[31]</xref>&#x02013;<xref rid="pone.0019825-Goto1" ref-type="bibr">[33]</xref>. The analysis indicated that marchantin fits well into the active pocket of PA endonuclease (<xref ref-type="fig" rid="pone-0019825-g003">Fig. 3A, B</xref>). PA endonuclease harbors two Mn<sup>2&#x0002b;</sup> ions in its active site (<xref ref-type="fig" rid="pone-0019825-g003">Fig. 3A</xref>) <xref rid="pone.0019825-Zhao1" ref-type="bibr">[30]</xref> which are important for its activity <xref rid="pone.0019825-Yuan1" ref-type="bibr">[15]</xref>, <xref rid="pone.0019825-Dias1" ref-type="bibr">[16]</xref>. Our docking simulation experiments further revealed that the dihydroxy group in the dihydroxyphenethyl group of marchantin E chelates the Mn<sup>2&#x0002b;</sup> ions within PA endonuclease (<xref ref-type="fig" rid="pone-0019825-g003">Fig. 3C</xref>). This dihydroxy group also interacts with several active amino acids (<xref ref-type="fig" rid="pone-0019825-g003">Fig. 3C</xref>). The aromatic rings and methoxy group of marchantin E bind to the active pocket of PA endonuclease through a hydrophobic interaction (<xref ref-type="fig" rid="pone-0019825-g003">Fig. 3C</xref>). We further performed docking simulation analysis of marchantin A with PA endonuclease and the results were almost identical. This docking analysis is consistent with our observations of endonuclease inhibition, and confirms the importance of the dihydroxyphenethyl group.</p><fig id="pone-0019825-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0019825.g003</object-id><label>Figure 3</label><caption><title>Docking simulation of marchantin E with influenza PA endonuclease.</title><p>
<bold>A)</bold> Docking simulation analysis of marchantin E with the PA endonuclease domain of the influenza A RNA polymerase. PA endonuclease is depicted as a ribbon structure. The &#x003b1;-helix and &#x003b2;-strands are shown in red and yellow, respectively. Manganese ions in the PA endonuclease are shown as cyan. Marchantin E is shown as a stick structure with oxygen atoms indicated in red. <bold>B)</bold> The fitting of marchantin E to the active pocket of the PA endonuclease. Marchantin E is displayed in a sphere mode. The surface of the pocket of the PA endonuclease is indicated in green and purple. The grey and red balls indicate carbon and oxygen atoms in marchantin E, respectively. <bold>C)</bold> Two dimensional analysis of the interaction between marchantin E and PA endonuclease. The chemical structure of marchantin E is shown in the center with the key interacting amino acids shown around it. The dihydroxyphenyl group of marchantin E interacts with two manganese ions. The hydroxy groups of marchantin bind to amino acids in PA endonuclease.</p></caption><graphic xlink:href="pone.0019825.g003"/></fig></sec><sec id="s2c"><title>Inhibition of influenza A and B viruses by marchantins</title><p>Following <italic>in vitro</italic> selection using the endonuclease-inhibition assay, as a second screening, we next examined the anti-viral activity of MA, ME, perrottetin F and plagiochin A against the influenza strains A/Hiroshima/52/2006 (H3N2), A/Solomon/3/2006 (H1N1) and B/Malaysia/2506/2004. As a control, two phytochemicals, marchantin A trimethoxy and isomarchantin C, which do not inhibit PA endonuclease, were also examined. The phytochemicals and viruses were mixed and then added to cultures of Madin-Darby canine kidney (MDCK) cells <xref rid="pone.0019825-Taub1" ref-type="bibr">[34]</xref>. As shown in <xref ref-type="fig" rid="pone-0019825-g004">Figure 4</xref>, the blue color indicates viable cells, indicating that the influenza virus had been inhibited <xref rid="pone.0019825-Virology1" ref-type="bibr">[35]</xref>. Marchantin E showed the strongest anti-influenza activity against the A/Hiroshima/52/2006 (H3N2) and A/Solomon/3/2006 (H1N1) viruses at a 50 &#x000b5;M concentration (<xref ref-type="fig" rid="pone-0019825-g004">Fig. 4A, B</xref>), and against B/Malaysia/2506/2004 virus at a 25 &#x000b5;M dose (<xref ref-type="fig" rid="pone-0019825-g004">Fig. 4C</xref>). Marchantin A and perrottetin F were found to have inhibitory activity against the B/Malaysia/2506/2004 virus at 50 &#x000b5;M (<xref ref-type="fig" rid="pone-0019825-g004">Fig. 4</xref>). The other compounds and DMSO solvent alone (negative control) did not show anti-influenza activity. All of the inhibitory phytochemicals also showed PA endonuclease-inhibition activity and harbor a dihydroxyphenethyl group within their structures. This demonstrates that the <italic>in vitro</italic> PA endonuclease activity assay is a useful tool for the screening of potential anti-influenza chemicals and also confirms the importance of the dihydroxyphenethyl group for anti-influenza activity.</p><fig id="pone-0019825-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0019825.g004</object-id><label>Figure 4</label><caption><title>Anti-influenza activity of marchantins.</title><p>Inhibition of the growth of influenza A or B viral by phytochemicals. MDCK cells were treated with influenza A/Hiroshima/52/2006 (H3N2) (<bold>A</bold>), A/Solomon/3/2006 (H1N1) (<bold>B</bold>) or B/Malaysia/2506/2004 (<bold>C</bold>) viruses. The cells were then treated with various concentrations of phytochemicals (6.25&#x02013;50 &#x000b5;M), some of which suppressed viral-induced cell death. DMSO was used as the phytochemical solvent.</p></caption><graphic xlink:href="pone.0019825.g004"/></fig><p>To examine whether marchantins can decrease the viral infectivity titer or not, we performed a focus-formation assay <xref rid="pone.0019825-Okuno1" ref-type="bibr">[36]</xref> without pre-incubation prior to infection. This assay determines viral growth in cells and can exclude the possibility of virus-absorption effects. We counted the viral foci using the PAP (peroxidase anti-peroxidase) method along with time course. The raw data are shown in <xref ref-type="supplementary-material" rid="pone.0019825.s001">Table S1</xref> and the results are summarized in <xref ref-type="table" rid="pone-0019825-t001">Table 1</xref> and <xref ref-type="fig" rid="pone-0019825-g005">Figure 5</xref>. The marchantins and related chemicals decreased viral focus-formation in a dose-dependent manner, indicating that these compounds inhibit viral growth in host cells. Among these chemicals, MA, ME and PeF showed the strongest activity at 50 &#x000b5;M, as shown in <xref ref-type="table" rid="pone-0019825-t001">Table 1</xref> (highlighted in blue). MA, ME and PeF each contain a dihydroxyphenethyl group, again confirming the importance of this moiety. Marchantin E showed the strongest activity (<xref ref-type="table" rid="pone-0019825-t001">Table 1</xref>). These results are consistent with the data shown in <xref ref-type="fig" rid="pone-0019825-g004">Figure 4</xref>.</p><fig id="pone-0019825-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0019825.g005</object-id><label>Figure 5</label><caption><title>Decrease of the viral infectivity titer by marchantins.</title><p>Decrease of viral infectivity titer of influenza B viral by phytochemicals. MDCK cells were treated with influenza B/Malashia/2506/2004 virus. The cells were then treated with various concentrations of phytochemicals (3.1&#x02013;50 &#x000b5;M), some of which decreased viral infectivity titer. DMSO was used as the phytochemicals solvent. (<bold>A</bold>) Viral growth curve under exposure to various concentrations of marchantins. The horizontal axis is the culture time and the vertical axis is the logarithm of virus infectivity titer (focus formation unit (FFU)). (<bold>B</bold>) Viral growth curve in the presence of marchantins and comparisons of the same concentration. The horizontal axis is the culture time and the vertical axis is the logarithm of virus infectivity titer (focus formation unit (FFU)).</p></caption><graphic xlink:href="pone.0019825.g005"/></fig><table-wrap id="pone-0019825-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0019825.t001</object-id><label>Table 1</label><caption><title>Specific activity of marchantins against viral infectivity titer.</title></caption><alternatives><graphic id="pone-0019825-t001-1" xlink:href="pone.0019825.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Chemicals</td><td align="left" rowspan="1" colspan="1">Conc. (&#x000b5;M)</td><td colspan="3" align="left" rowspan="1">Log (Focus formation unit/ml)</td><td align="left" rowspan="1" colspan="1">Dihydroxy phenethyl group</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">24 (hr)</td><td align="left" rowspan="1" colspan="1">48 (hr)</td><td align="left" rowspan="1" colspan="1">72 (hr)</td><td align="left" rowspan="1" colspan="1"/></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">MA</td><td align="left" rowspan="1" colspan="1">50</td><td align="left" rowspan="1" colspan="1">2.7</td><td align="left" rowspan="1" colspan="1">4.04</td><td align="left" rowspan="1" colspan="1">4.9</td><td align="left" rowspan="1" colspan="1">&#x0002b;</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">13</td><td align="left" rowspan="1" colspan="1">2.85</td><td align="left" rowspan="1" colspan="1">4.62</td><td align="left" rowspan="1" colspan="1">5.16</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">3.1</td><td align="left" rowspan="1" colspan="1">2.78</td><td align="left" rowspan="1" colspan="1">4.64</td><td align="left" rowspan="1" colspan="1">5.87</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">MAt</td><td align="left" rowspan="1" colspan="1">50</td><td align="left" rowspan="1" colspan="1">2.7</td><td align="left" rowspan="1" colspan="1">4.24</td><td align="left" rowspan="1" colspan="1">5.12</td><td align="left" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">13</td><td align="left" rowspan="1" colspan="1">2.85</td><td align="left" rowspan="1" colspan="1">4.86</td><td align="left" rowspan="1" colspan="1">5.22</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">3.1</td><td align="left" rowspan="1" colspan="1">2.9</td><td align="left" rowspan="1" colspan="1">4.5</td><td align="left" rowspan="1" colspan="1">5.97</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">ME</td><td align="left" rowspan="1" colspan="1">50</td><td align="left" rowspan="1" colspan="1">2.7</td><td align="left" rowspan="1" colspan="1">4.3</td><td align="left" rowspan="1" colspan="1">4.64</td><td align="left" rowspan="1" colspan="1">&#x0002b;</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">13</td><td align="left" rowspan="1" colspan="1">2.7</td><td align="left" rowspan="1" colspan="1">4.59</td><td align="left" rowspan="1" colspan="1">5.1</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">3.1</td><td align="left" rowspan="1" colspan="1">3.04</td><td align="left" rowspan="1" colspan="1">4.6</td><td align="left" rowspan="1" colspan="1">5.71</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">RA</td><td align="left" rowspan="1" colspan="1">50</td><td align="left" rowspan="1" colspan="1">2.7</td><td align="left" rowspan="1" colspan="1">4.25</td><td align="left" rowspan="1" colspan="1">5.19</td><td align="left" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">13</td><td align="left" rowspan="1" colspan="1">2.9</td><td align="left" rowspan="1" colspan="1">4.9</td><td align="left" rowspan="1" colspan="1">5.1</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">3.1</td><td align="left" rowspan="1" colspan="1">3.04</td><td align="left" rowspan="1" colspan="1">4.65</td><td align="left" rowspan="1" colspan="1">5.88</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">PlA</td><td align="left" rowspan="1" colspan="1">50</td><td align="left" rowspan="1" colspan="1">2.9</td><td align="left" rowspan="1" colspan="1">4.27</td><td align="left" rowspan="1" colspan="1">4.97</td><td align="left" rowspan="1" colspan="1">&#x0002b;</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">13</td><td align="left" rowspan="1" colspan="1">2.95</td><td align="left" rowspan="1" colspan="1">4.95</td><td align="left" rowspan="1" colspan="1">5.13</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">3.1</td><td align="left" rowspan="1" colspan="1">2.85</td><td align="left" rowspan="1" colspan="1">4.96</td><td align="left" rowspan="1" colspan="1">5.72</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">PeF</td><td align="left" rowspan="1" colspan="1">50</td><td align="left" rowspan="1" colspan="1">2.9</td><td align="left" rowspan="1" colspan="1">4.15</td><td align="left" rowspan="1" colspan="1">4.85</td><td align="left" rowspan="1" colspan="1">&#x0002b;</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">13</td><td align="left" rowspan="1" colspan="1">2.7</td><td align="left" rowspan="1" colspan="1">4.51</td><td align="left" rowspan="1" colspan="1">5.12</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">3.1</td><td align="left" rowspan="1" colspan="1">2.6</td><td align="left" rowspan="1" colspan="1">4.7</td><td align="left" rowspan="1" colspan="1">5.92</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">DMSO (solvent)</td><td align="left" rowspan="1" colspan="1">50</td><td align="left" rowspan="1" colspan="1">2.9</td><td align="left" rowspan="1" colspan="1">4.5</td><td align="left" rowspan="1" colspan="1">5.82</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">13</td><td align="left" rowspan="1" colspan="1">2.78</td><td align="left" rowspan="1" colspan="1">4.73</td><td align="left" rowspan="1" colspan="1">5.79</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">3.1</td><td align="left" rowspan="1" colspan="1">2.6</td><td align="left" rowspan="1" colspan="1">4.64</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Negative control</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">2.9</td><td align="left" rowspan="1" colspan="1">5.15</td><td align="left" rowspan="1" colspan="1">5.89</td><td align="left" rowspan="1" colspan="1"/></tr></tbody></table></alternatives></table-wrap></sec><sec id="s2d"><title>Conserved amino acids important for docking between influenza A and B</title><p>Since marchantin E inhibits the growth of both influenza A and B (<xref ref-type="fig" rid="pone-0019825-g004">Fig. 4</xref>), we predicted that the amino acids in PA which are important for binding to marchantin E should be conserved between these virus strains. Using the clustal X program <xref rid="pone.0019825-Thompson1" ref-type="bibr">[37]</xref>, we compared the PA amino acid sequences of influenza A and B (<xref ref-type="fig" rid="pone-0019825-g006">Fig. 6</xref>). Glu23, His41, Glu80, Arg84, Asp108, Glu119 and Lys134 are the predicted docking amino acids as shown in <xref ref-type="fig" rid="pone-0019825-g002">Figure 2</xref> and are fully conserved (<xref ref-type="fig" rid="pone-0019825-g006">Fig. 6</xref>). The endonuclease-inhibition, anti-influenza activity and docking simulation results are thus highly consistent.</p><fig id="pone-0019825-g006" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0019825.g006</object-id><label>Figure 6</label><caption><title>Docking amino acids are conserved between influenza A and B.</title><p>The docking amino acids (Glu23, His41, Glu80, Arg84, Asp108, Glu119 and Lys134) identified in <xref ref-type="fig" rid="pone-0019825-g003">Figure 3</xref> are shown in an alignment of influenza A and B amino acid sequences. This alignment was generated using the clustal X program.</p></caption><graphic xlink:href="pone.0019825.g006"/></fig></sec><sec id="s2e"><title>Comparisons between marchantin and other inhibitors of influenza A</title><p>To determine whether a common active chemical group is contained among inhibitors of the influenza virus, we compared marchantin with other influenza and PA endonuclease inhibitors. Previously, we have reported that the green tea catechins, epigallocatechin gallate (EGCG) and epicatechin gallate (ECG) <xref rid="pone.0019825-Yang1" ref-type="bibr">[38]</xref>, <xref rid="pone.0019825-Song1" ref-type="bibr">[39]</xref> have these inhibitory properties <xref rid="pone.0019825-Kuzuhara2" ref-type="bibr">[17]</xref> (<xref ref-type="fig" rid="pone-0019825-g007">Fig. 7</xref>). We have also reported that several synthesized phthalimide chemicals, namely N-{2-[2-(3,4-dihydroxyphenyl)ethyl]phenyl}phthalimide and N-{3-[2-(3,4-dihydroxyphenyl)ethyl]phenyl}phthalimide also inhibit PA endonuclease and have anti-influenza activity <xref rid="pone.0019825-Iwai1" ref-type="bibr">[29]</xref> (<xref ref-type="fig" rid="pone-0019825-g007">Fig. 7</xref>). As marchantins and catechins are natural products, whereas the phenethylphenylphthalimides are synthetic, their structures are quite different (<xref ref-type="fig" rid="pone-0019825-g007">Fig. 7</xref>). Significantly however, all contain a dihydroxyphenethyl group (<xref ref-type="fig" rid="pone-0019825-g007">Fig. 7</xref>), again confirming its importance in conferring anti-influenza activity. Docking simulation analyses of marchantin A or EGCG with PA endonuclease showed that both these molecules chelate divalent manganese ions within PA endonuclease via dihydroxy groups (<xref ref-type="fig" rid="pone-0019825-g008">Fig. 8</xref>). These simulation analyses further underlie the importance of the dihydroxyphenethyl groups that are common to anti-influenza chemicals.</p><fig id="pone-0019825-g007" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0019825.g007</object-id><label>Figure 7</label><caption><title>Consensus structure of chemicals with anti-influenza activity.</title><p>Consensus structure of the phytochemicals and synthesized chemicals possessing anti-influenza A activity. The dihydroxyphenethyl group (shown as red) is common to marchantin, catechin and several phthalimide molecules which all inhibit the influenza virus.</p></caption><graphic xlink:href="pone.0019825.g007"/></fig><fig id="pone-0019825-g008" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0019825.g008</object-id><label>Figure 8</label><caption><title>Comparison between marchantins and catechins that bind to PA endonuclease.</title><p>Docking simulation analysis of marchantin A (panel A) or EGCG (panel B) with the PA endonuclease domain. Two dimensional analysis of the interactions of marchantin A or EGCG with PA endonuclease is shown. The chemical structures of marchantin A and EGCG is shown in the center. The interacting amino acids of PA endonuclease are shown around them. The dihydroxyphenyl groups of both marchantin A and EGCG interact with two manganese ions.</p></caption><graphic xlink:href="pone.0019825.g008"/></fig></sec></sec><sec id="s3"><title>Discussion</title><p>This is the first report to show that secondary metabolites from liverworts have anti-influenza activity. Marchantin has a unique macrocyclic structure, and is therefore a novel type of anti-influenza chemical. Whilst marchantin targets PA endonuclease, oseltamivir does so for neuraminidase. We speculated that a combination of marchantin and oseltamivir would be effective against influenza, because it can inhibit two independent steps that are essential for the growth of this virus. We believe therefore that a marchantin solution or a liverwort extract would likely be an efficient gargle for the prevention of influenza.</p><p>As shown in <xref ref-type="fig" rid="pone-0019825-g003">Figures 3c</xref> and <xref ref-type="fig" rid="pone-0019825-g008">8</xref>, the amino acids in PA that are important for docking with marchantin A or E are common (also see <xref ref-type="fig" rid="pone-0019825-g008">Fig. 8</xref>). We speculate that the small differences in the docking mode between marchantin A and E that we observed may be due to the methoxy group of marchantin E. Based on our present analyses, we propose a &#x0201c;fitting and chelating model&#x0201d; as the mechanism by which marchantin and its related chemicals inhibit the influenza PA endonuclease. These data thus represent an important advance for future strategies to refine marchantin-based drug design using an <italic>in silico</italic> binding simulation with PA. Our structure-function relationship analysis and docking simulation analysis also provide valuable new information for the design of novel anti-influenza drugs.</p></sec><sec sec-type="materials|methods" id="s4"><title>Materials and Methods</title><sec id="s4a"><title>Purification of phytochemicals</title><p>Marchantins were isolated from the methanol extracts of <italic>Marchantia polymorpha</italic> and <italic>M. paleacea</italic> var. <italic>diptera</italic>
<xref rid="pone.0019825-Asakawa2" ref-type="bibr">[19]</xref>, <xref rid="pone.0019825-Asakawa7" ref-type="bibr">[24]</xref>, perrottetin F from <italic>Plagiochila sciophila</italic>, and plagiochin A from <italic>Radula kojana</italic>. Daldinol, daldinals A and B, daldinin C and ergosta-4,6,8 (14), 22-tetraen-3-one were isolated from the fungus <italic>Daldinia concentrica</italic>
<xref rid="pone.0019825-Hashimoto1" ref-type="bibr">[40]</xref>, <xref rid="pone.0019825-Hashimoto2" ref-type="bibr">[41]</xref>. 5, 6-Dehydrokawain, kawain, dihydrokawain, methysticin and yangonin were isolated from Fijian Kawa (<italic>Piper methysticum</italic>) <xref rid="pone.0019825-Hashimoto3" ref-type="bibr">[42]</xref>. Osumundalactone was isolated from the fungus <italic>Paxillus atromentosus</italic>
<xref rid="pone.0019825-Buchanan1" ref-type="bibr">[43]</xref>. 8-Methoxypsoralen, 5-methoxypsoralen, isopimpinellin, osthol and imperatprin were isolated from the fruits of <italic>Cnidium monnieri</italic>, belonging to the Umbelliferae. Phellopterin, isoimperatorin and heraclenin (also known as pragenin) were isolated from the root of <italic>Angelica dahurica</italic>, also belonging to the Umbelliferae. Magnolol and honokiol were isolated from the bark of the <italic>Magnolia obovata</italic> belonging to the Magnoliaceae. Lycogarbins A and B were isolated from the slime molds (Myxomycete) <italic>Lycogala epidendrum</italic>
<xref rid="pone.0019825-Hashimoto4" ref-type="bibr">[44]</xref>.</p></sec><sec id="s4b"><title>Expression and purification of the PA endonuclease domain</title><p>The influenza (A/PR/8/34) H1N1 RNA polymerase PA plasmid, pBMSA-PA, was sourced from the DNA Bank, Riken BioResource Center (Tsukuba, Japan; originally deposited by Dr. Susumu Nakada) <xref rid="pone.0019825-Nakamura1" ref-type="bibr">[45]</xref>. The cDNA fragment corresponding to the PA N-terminal endonuclease domain (residues 1&#x02013;220) was amplified by PCR <xref rid="pone.0019825-Mullis1" ref-type="bibr">[46]</xref> from pBMSA-PA using the primers PA endonuclease forward <italic>Nde</italic>I, <named-content content-type="gene">GCC GTT CAT ATG GAA GAT TTT GTG CGA CAA</named-content> and PA endonuclease reverse <italic>Bam</italic>HI, GCC<named-content content-type="gene"> GTT GGA TCC TAT TGG TCG GCA AGC TTG CG</named-content>. The amplified product was then subcloned into the pET28a(&#x0002b;) plasmid (Novagen, Madison, WI) at the <italic>Nde</italic>I and <italic>Bam</italic>HI restriction sites. The resulting construct was then introduced into BL21-CodonPlus <italic>E. coli</italic> cells (Stratagene, La Jolla, CA). The induction of 6x his-tagged recombinant protein expression from these constructs was achieved by the addition of isopropyl -D-thiogalactopyranoside (IPTG) <xref rid="pone.0019825-Studier1" ref-type="bibr">[47]</xref> to the bacterial cultures in TBG-M9 medium and this was followed by purification using Ni<sup>2&#x0002b;</sup>-agarose <xref rid="pone.0019825-Janknecht1" ref-type="bibr">[48]</xref>. The recombinant PA endonuclease domain protein was further purified to near homogeneity using a HiTrap&#x02122; Q FF column (GE Healthcare, Buckinghamshire, UK) with the AKTA&#x02122; prime plus system (GE Healthcare).</p></sec><sec id="s4c"><title>PA endonuclease activity assay</title><p>Influenza A RNA polymerase PA endonuclease activity assays were performed essentially as described by Dias <italic>et al</italic>. <xref rid="pone.0019825-Kuzuhara1" ref-type="bibr">[14]</xref>&#x02013;<xref rid="pone.0019825-Dias1" ref-type="bibr">[16]</xref> with some modifications. Briefly, the pH conditions were modified from 8.0 to 7.3 and 1 &#x000b5;g of M13mp18 single stranded circular phage DNA was used as the assay substrate. A total of 0.35 &#x000b5;g of recombinant PA endonuclease domain was added to 100 &#x000b5;l of assay buffer in each reaction (the final concentration of the protein was about 0.1 &#x000b5;M). Phytochemicals (summarized in <xref ref-type="fig" rid="pone-0019825-g001">Fig. 1</xref>) were then added to the reaction and products were analyzed by agarose electrophoresis and stained with ethidium bromide.</p></sec><sec id="s4d"><title>Inhibition of viral growth</title><p>Madin-Darby canine kidney (MDCK) cells <xref rid="pone.0019825-Taub1" ref-type="bibr">[34]</xref> were cultured in MEM (minimum essential medium; Gibco/Invitrogen, Carlsbad, CA) supplemented with 10&#x00025; fetal bovine serum in a 5&#x00025; CO<sub>2</sub> incubator at 37 &#x000b0;C. A confluent monolayer of MDCK cells was prepared in each well of a 96 well plate. Various concentrations (6.25&#x02013;50 &#x000b5;M) of phytochemicals were then mixed with TCID<sub>50</sub> (fifty-percent of the infectious dose) of A/Hiroshima/52/2006 (H3N2), A/Solomon/3/2006 (H1N1) or B/Malashia/2506/2004 influenza strains and incubated at 37&#x000b0;C for 30 min <xref rid="pone.0019825-Virology1" ref-type="bibr">[35]</xref>. The MDCK cells were then washed with PBS(-) and the viral mixture was added to the cells. Treated cells were then incubated for four days at 34&#x000b0;C under 5&#x00025; CO<sub>2</sub>. After incubation, the medium was removed and cells were fixed with a 10&#x00025; formaldehyde solution. Viable cells were stained with NB solution (0.1&#x00025; napthol blue black, 0.1&#x00025; sodium acetate and 9&#x00025; acetic acid) <xref rid="pone.0019825-Virology1" ref-type="bibr">[35]</xref>.</p></sec><sec id="s4e"><title>Focus-formation assay</title><p>MDCK cells were incubated on micro plates (24-well) at 37 &#x000b0;C for three days in a CO<sub>2</sub> incubator. The cells were washed with PBS(-) and influenza virus (B/Malaysia/2506/2004) solution was added at an m.o.i of 0.001. Viruses were absorbed on cells at 37 &#x000b0;C for 30 min and the cells were washed by PBS(-) to remove unabsorbed virus. Concentrations of 50, 12.5 or 3.1 &#x000b5;M of chemicals in growth medium were added into each well. The cells were then incubated at 37&#x000b0;C for three days and a portion of the supernatant was sampled each day. The sampled supernatants were subjected to a focus forming unit (FFU) assay using the PAP (rabbit peroxidase anti-peroxidase) method. Fresh MDCK cells were incubated in micro plates (96-well) at 37&#x000b0;C for three days. The obtained virus solutions were 10-fold titrated in micro plates (from 10 to 10<sup>8</sup> times). The cells were then washed with PBS(-) and 100 &#x000b5;l of the titrated virus solutions was added to the cells. Viruses were absorbed on the cells at 37&#x000b0;C for 60 min with shaking at 15 min intervals. The cells were washed with PBS(-) to remove unabsorbed virus and MEM medium (serum (-)) was then added, followed by an incubation at 37 &#x000b0;C for 1 day. Supernatant was removed and cells were fixed with ethanol for 10 min at room temperature. The ethanol was then removed and cells were dried.</p><p>The staining of foci via the PAP method was performed as follows: 50 &#x000b5;l of a 1000 fold-dilution of the primary antibody (mouse anti-influenza A or B NP serum) was added to each well and incubated at 37 &#x000b0;C for 30 min. Each well was washed with PBS(-). 50 &#x000b5;l of a 1&#x02236;1000 dilution of secondary antibody (rabbit anti-mouse IgG serum) was then added into each well and incubated at 37 &#x000b0;C for 30 min. Each well was further washed in PBS(-). 50 &#x000b5;l of a 1&#x02236;500 dilution of a third antibody (goat anti-rabbit IgG serum) was next added into each well and the cells were treated as before. Finally, 50 &#x000b5;l of a 1&#x02236;10000 PAP complex solution was added to each well and incubated at 37&#x000b0;C for 30 min. Each well was washed by PBS(-). This was followed by the addition of 50 &#x000b5;l of substrate (3,3&#x02032;-diaminobenzidin tetrahydrochloride) for 10&#x02013;15 min at room temperature, washing with water and drying. The infectivity titer (FFU) was calculated by counting the numbers of foci i.e. numbers of foci per well x titration of virus solution x 1000 / 100 (volume of virus solution)&#x0200a;=&#x0200a;infectivity titer (FFU/ml).</p></sec><sec id="s4f"><title>
<italic>In silico</italic> docking simulation analyses of marchantins and catechin with the PA endonuclease domain of influenza A</title><p>All molecular modeling studies were performed using Molecular Operating Environment (MOE; Chemical Computing Group, Quebec, Canada) software <xref rid="pone.0019825-Morris1" ref-type="bibr">[31]</xref>&#x02013;<xref rid="pone.0019825-Goto1" ref-type="bibr">[33]</xref>. The X-ray crystallographic structure of the endonuclease domain of PA subunit of influenza A virus RNA dependent RNA polymerase (PDB ID: 3HW5) was obtained from a protein data bank <xref rid="pone.0019825-Zhao1" ref-type="bibr">[30]</xref>. This enzyme was prepared for docking studies in which (i) the ligand molecule was removed from the enzyme active site; (ii) hydrogen atoms were added to the structure with a standard geometry; (iii) the structure was minimized using a MMFF94s force-field; (iv) MOE Alpha Site Finder was used for active site searches within the enzyme structure and dummy atoms were created from the obtained alpha spheres; and (v) the obtained model was then used in the ASEDock program (Ryoka Systems Inc., Tokyo, Japan). A total of 250 conformations of marchantin A or E were generated by Low Mode MD. The used parameters in step 1 were as follows: cut off value, 4.5; RMS gradient, 10; and energy threshold, 500. The used parameters in step 2 (optimization) were as follows: cut off value,8; RMS gradient, 0.1.</p></sec></sec><sec sec-type="supplementary-material" id="s5"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pone.0019825.s001"><label>Table S1</label><caption><p>
<bold>Effect of marchantins on viral infectivity titer (raw data).</bold> We tested the effects of marchantins on viral infectivity-titer and counted the viral foci along with time course. This raw data are calculated and summarized in <xref ref-type="table" rid="pone-0019825-t001">Table 1</xref> and presented as graphs in <xref ref-type="fig" rid="pone-0019825-g005">Figure 5</xref>.</p><p>(XLS)</p></caption><media xlink:href="pone.0019825.s001.xls"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>The influenza virus (A/PR/8/34) RNA polymerase PA plasmid, pBMSA-PA, was provided by the DNA Bank, RIKEN BioResource Center (Tsukuba, Japan; originally deposited by Dr. Susumu Nakada) with the support of National Bio-Resources Project of the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT).</p></ack><fn-group><fn fn-type="COI-statement"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding: </bold>This work was supported in part by a Grant-in-Aid from the Japan Society for the Promotion of Science (JSPS), and funding from Tokushima Bunri University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></fn></fn-group><ref-list><title>References</title><ref id="pone.0019825-Taubenberger1"><label>1</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Taubenberger</surname><given-names>JK</given-names></name><name><surname>Reid</surname><given-names>AH</given-names></name><name><surname>Lourens</surname><given-names>RM</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Jin</surname><given-names>G</given-names></name><etal/></person-group>
<year>2005</year>
<article-title>Characterization of the 1918 influenza virus polymerase genes.</article-title>
<source>Nature</source>
<volume>437</volume>
<fpage>889</fpage>
<lpage>893</lpage>
<pub-id pub-id-type="pmid">16208372</pub-id></element-citation></ref><ref id="pone.0019825-Morse1"><label>2</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Morse</surname><given-names>SS</given-names></name></person-group>
<year>2007</year>
<article-title>The US pandemic influenza implementation plan at six months.</article-title>
<source>Nat Med</source>
<volume>13</volume>
<fpage>681</fpage>
<lpage>684</lpage>
<pub-id pub-id-type="pmid">17554335</pub-id></element-citation></ref><ref id="pone.0019825-Horimoto1"><label>3</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Horimoto</surname><given-names>T</given-names></name><name><surname>Kawaoka</surname><given-names>Y</given-names></name></person-group>
<year>2005</year>
<article-title>Influenza: lessons from past pandemics, warnings from current incidents.</article-title>
<source>Nat Rev Microbiol</source>
<volume>3</volume>
<fpage>591</fpage>
<lpage>600</lpage>
<pub-id pub-id-type="pmid">16064053</pub-id></element-citation></ref><ref id="pone.0019825-Hatta1"><label>4</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hatta</surname><given-names>M</given-names></name><name><surname>Gao</surname><given-names>P</given-names></name><name><surname>Halfmann</surname><given-names>P</given-names></name><name><surname>Kawaoka</surname><given-names>Y</given-names></name></person-group>
<year>2001</year>
<article-title>Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses.</article-title>
<source>Science</source>
<volume>293</volume>
<fpage>1840</fpage>
<lpage>1842</lpage>
<pub-id pub-id-type="pmid">11546875</pub-id></element-citation></ref><ref id="pone.0019825-Itoh1"><label>5</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Itoh</surname><given-names>Y</given-names></name><name><surname>Shinya</surname><given-names>K</given-names></name><name><surname>Kiso</surname><given-names>M</given-names></name><name><surname>Watanabe</surname><given-names>T</given-names></name><name><surname>Sakoda</surname><given-names>Y</given-names></name><etal/></person-group>
<year>2009</year>
<article-title>
<italic>In vitro</italic> and <italic>in vivo</italic> characterization of new swine-origin H1N1 influenza viruses.</article-title>
<source>Nature</source>
<volume>460</volume>
<fpage>1021</fpage>
<lpage>1025</lpage>
<pub-id pub-id-type="pmid">19672242</pub-id></element-citation></ref><ref id="pone.0019825-Neumann1"><label>6</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Neumann</surname><given-names>G</given-names></name><name><surname>Noda</surname><given-names>T</given-names></name><name><surname>Kawaoka</surname><given-names>Y</given-names></name></person-group>
<year>2009</year>
<article-title>Emergence and pandemic potential of swine-origin H1N1 influenza virus.</article-title>
<source>Nature</source>
<volume>459</volume>
<fpage>931</fpage>
<lpage>939</lpage>
<pub-id pub-id-type="pmid">19525932</pub-id></element-citation></ref><ref id="pone.0019825-DeClercq1"><label>7</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>De Clercq</surname><given-names>E</given-names></name></person-group>
<year>2006</year>
<article-title>Antiviral agents active against influenza A viruses.</article-title>
<source>Nat Rev Drug Discov</source>
<volume>5</volume>
<fpage>1015</fpage>
<lpage>1025</lpage>
<pub-id pub-id-type="pmid">17139286</pub-id></element-citation></ref><ref id="pone.0019825-Hayden1"><label>8</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hayden</surname><given-names>FG</given-names></name><name><surname>Atmar</surname><given-names>RL</given-names></name><name><surname>Schilling</surname><given-names>M</given-names></name><name><surname>Johnson</surname><given-names>C</given-names></name><name><surname>Poretz</surname><given-names>D</given-names></name><etal/></person-group>
<year>1999</year>
<article-title>Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza.</article-title>
<source>N Engl J Med</source>
<volume>341</volume>
<fpage>1336</fpage>
<lpage>1343</lpage>
<pub-id pub-id-type="pmid">10536125</pub-id></element-citation></ref><ref id="pone.0019825-Reece1"><label>9</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Reece</surname><given-names>PA</given-names></name></person-group>
<year>2007</year>
<article-title>Neuraminidase inhibitor resistance in influenza viruses.</article-title>
<source>J Med Virol</source>
<volume>79</volume>
<fpage>1577</fpage>
<lpage>1586</lpage>
<pub-id pub-id-type="pmid">17705169</pub-id></element-citation></ref><ref id="pone.0019825-Collins1"><label>10</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Collins</surname><given-names>PJ</given-names></name><name><surname>Haire</surname><given-names>LF</given-names></name><name><surname>Lin</surname><given-names>YP</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Russell</surname><given-names>RJ</given-names></name><etal/></person-group>
<year>2008</year>
<article-title>Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants.</article-title>
<source>Nature</source>
<volume>453</volume>
<fpage>1258</fpage>
<lpage>1261</lpage>
<pub-id pub-id-type="pmid">18480754</pub-id></element-citation></ref><ref id="pone.0019825-Izumi1"><label>11</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Izumi</surname><given-names>Y</given-names></name><name><surname>Tokuda</surname><given-names>K</given-names></name><name><surname>O'dell</surname><given-names>KA</given-names></name><name><surname>Zorumski</surname><given-names>CF</given-names></name><name><surname>Narahashi</surname><given-names>T</given-names></name></person-group>
<year>2007</year>
<article-title>Neuroexcitatory actions of Tamiflu and its carboxylate metabolite.</article-title>
<source>Neurosci Lett</source>
<volume>426</volume>
<fpage>54</fpage>
<lpage>58</lpage>
<pub-id pub-id-type="pmid">17884292</pub-id></element-citation></ref><ref id="pone.0019825-Honda1"><label>12</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Honda</surname><given-names>A</given-names></name><name><surname>Ishihama</surname><given-names>A</given-names></name></person-group>
<year>1997</year>
<article-title>The molecular anatomy of influenza virus RNA polymerase.</article-title>
<source>Biol Chem</source>
<volume>378</volume>
<fpage>483</fpage>
<lpage>488</lpage>
<pub-id pub-id-type="pmid">9224927</pub-id></element-citation></ref><ref id="pone.0019825-Honda2"><label>13</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Honda</surname><given-names>A</given-names></name><name><surname>Mizumoto</surname><given-names>K</given-names></name><name><surname>Ishihama</surname><given-names>A</given-names></name></person-group>
<year>2002</year>
<article-title>Minimum molecular architectures for transcription and replication of the influenza virus.</article-title>
<source>Proc Natl Acad Sci U S A</source>
<volume>99</volume>
<fpage>13166</fpage>
<lpage>13171</lpage>
<pub-id pub-id-type="pmid">12271117</pub-id></element-citation></ref><ref id="pone.0019825-Kuzuhara1"><label>14</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kuzuhara</surname><given-names>T</given-names></name><name><surname>Kise</surname><given-names>D</given-names></name><name><surname>Yoshida</surname><given-names>H</given-names></name><name><surname>Horita</surname><given-names>T</given-names></name><name><surname>Murazaki</surname><given-names>Y</given-names></name><etal/></person-group>
<year>2009</year>
<article-title>Structural basis of the influenza A virus RNA polymerase PB2 RNA-binding domain containing the pathogenicity-determinant lysine 627 residue.</article-title>
<source>J Biol Chem</source>
<volume>284</volume>
<fpage>6855</fpage>
<lpage>6860</lpage>
<pub-id pub-id-type="pmid">19144639</pub-id></element-citation></ref><ref id="pone.0019825-Yuan1"><label>15</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yuan</surname><given-names>P</given-names></name><name><surname>Bartlam</surname><given-names>M</given-names></name><name><surname>Lou</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><etal/></person-group>
<year>2009</year>
<article-title>Crystal structure of an avian influenza polymerase PA(N) reveals an endonuclease active site.</article-title>
<source>Nature</source>
<volume>458</volume>
<fpage>909</fpage>
<lpage>913</lpage>
<pub-id pub-id-type="pmid">19194458</pub-id></element-citation></ref><ref id="pone.0019825-Dias1"><label>16</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dias</surname><given-names>A</given-names></name><name><surname>Bouvier</surname><given-names>D</given-names></name><name><surname>Cr&#x000e9;pin</surname><given-names>T</given-names></name><name><surname>McCarthy</surname><given-names>AA</given-names></name><name><surname>Hart</surname><given-names>DJ</given-names></name><etal/></person-group>
<year>2009</year>
<article-title>The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit.</article-title>
<source>Nature</source>
<volume>458</volume>
<fpage>914</fpage>
<lpage>918</lpage>
<pub-id pub-id-type="pmid">19194459</pub-id></element-citation></ref><ref id="pone.0019825-Kuzuhara2"><label>17</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kuzuhara</surname><given-names>T</given-names></name><name><surname>Iwai</surname><given-names>Y</given-names></name><name><surname>Takahashi</surname><given-names>H</given-names></name><name><surname>Hatakeyama</surname><given-names>D</given-names></name><name><surname>Echigo</surname><given-names>N</given-names></name></person-group>
<year>2009</year>
<article-title>Green tea catechins inhibit the endonuclease activity of influenza A virus RNA polymerase.</article-title>
<source>PLoS Curr Oct</source>
<volume>13</volume>
<fpage>RRN1052</fpage>
</element-citation></ref><ref id="pone.0019825-Asakawa1"><label>18</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Asakawa</surname><given-names>Y</given-names></name></person-group>
<year>1982</year>
<article-title>Progress in the Chemistry of Organic Natural Products. Vol 42,</article-title>
<person-group person-group-type="editor"><name><surname>Herz</surname><given-names>W</given-names></name><name><surname>Grisebach</surname><given-names>H</given-names></name><name><surname>Kirby</surname><given-names>GW</given-names></name></person-group>
<publisher-loc>Vienna</publisher-loc>
<publisher-name>Springer</publisher-name>
<fpage>1</fpage>
<lpage>285</lpage>
</element-citation></ref><ref id="pone.0019825-Asakawa2"><label>19</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Asakawa</surname><given-names>Y</given-names></name></person-group>
<year>1995</year>
<article-title>Progress in the Chemistry of Organic Natural Products. Vol 65,</article-title>
<person-group person-group-type="editor"><name><surname>Herz</surname><given-names>W</given-names></name><name><surname>Kirby</surname><given-names>GW</given-names></name><name><surname>Moore</surname><given-names>RE</given-names></name><name><surname>Steglich</surname><given-names>W</given-names></name><name><surname>Tamm</surname><given-names>Ch</given-names></name></person-group>
<publisher-loc>Vienna</publisher-loc>
<publisher-name>Springer</publisher-name>
<fpage>1</fpage>
<lpage>618</lpage>
</element-citation></ref><ref id="pone.0019825-Asakawa3"><label>20</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Asakawa</surname><given-names>Y</given-names></name></person-group>
<year>2004</year>
<article-title>Phytochemistry 65,</article-title>
<fpage>623</fpage>
<lpage>669</lpage>
</element-citation></ref><ref id="pone.0019825-Asakawa4"><label>21</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Asakawa</surname><given-names>Y</given-names></name></person-group>
<year>2008</year>
<article-title>Curr Pharm Design 14,</article-title>
<fpage>3067</fpage>
<lpage>3088</lpage>
</element-citation></ref><ref id="pone.0019825-Asakawa5"><label>22</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Asakawa</surname><given-names>Y</given-names></name></person-group>
<year>1999</year>
<article-title>Phytochemicals in Human Health Protection, Nutrition, and Plant Defense.</article-title>
<person-group person-group-type="editor"><name><surname>Romeo</surname><given-names>J</given-names></name></person-group>
<publisher-loc>New York</publisher-loc>
<publisher-name>Kluwer Academic/Prenum Publishers</publisher-name>
<fpage>319</fpage>
<lpage>342</lpage>
</element-citation></ref><ref id="pone.0019825-Asakawa6"><label>23</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Asakawa</surname><given-names>Y</given-names></name></person-group>
<year>1990</year>
<article-title>Bryophytes Their Chemistry and Chemotaxonomy of Bryophytes.</article-title>
<person-group person-group-type="editor"><name><surname>Zinsmeister</surname><given-names>DH</given-names></name><name><surname>Mues</surname><given-names>R</given-names></name></person-group>
<publisher-loc>Oxford</publisher-loc>
<publisher-name>Clarendon Press</publisher-name>
<fpage>369</fpage>
<lpage>410</lpage>
</element-citation></ref><ref id="pone.0019825-Asakawa7"><label>24</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Asakawa</surname><given-names>Y</given-names></name><name><surname>Agnieszka</surname><given-names>L</given-names></name><name><surname>Nagashima</surname><given-names>F</given-names></name><name><surname>Toyota</surname><given-names>M</given-names></name><name><surname>Hashimoto</surname><given-names>T</given-names></name><etal/></person-group>
<year>2009</year>
<article-title>Bryophytes: bio- and chemical diversity, bioactivity and chemosystematics.</article-title>
<source>Heterocycles</source>
<volume>77</volume>
<fpage>99</fpage>
<lpage>150</lpage>
</element-citation></ref><ref id="pone.0019825-Suzuki1"><label>25</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>T</given-names></name><name><surname>Tamehiro</surname><given-names>N</given-names></name><name><surname>Sato</surname><given-names>Y</given-names></name><name><surname>Kobayashi</surname><given-names>T</given-names></name><name><surname>Ishii-Watabe</surname><given-names>A</given-names></name><etal/></person-group>
<year>2008</year>
<article-title>The Novel Compounds that Activate Farnesoid X Receptor: the Diversity of Their Effects on Gene Expression.</article-title>
<source>J P0harmacol Sci</source>
<volume>107</volume>
<fpage>285</fpage>
<lpage>294</lpage>
</element-citation></ref><ref id="pone.0019825-Morita1"><label>26</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Morita</surname><given-names>H</given-names></name><name><surname>Tomizawa</surname><given-names>Y</given-names></name><name><surname>Tsuchiya</surname><given-names>T</given-names></name><name><surname>Hirasawa</surname><given-names>Y</given-names></name><name><surname>Hashimoto</surname><given-names>T</given-names></name><etal/></person-group>
<year>2009</year>
<article-title>Antimitotic Activity of Two Macrocyclic Bis(bibenzyls), Isoplagiochins A and B from the Liverwort Plagiochila fruticosa.</article-title>
<source>Bioorg Med Chem Lett,</source>
<volume>19</volume>
<fpage>493</fpage>
<lpage>496</lpage>
<pub-id pub-id-type="pmid">19056262</pub-id></element-citation></ref><ref id="pone.0019825-Taira1"><label>27</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Taira</surname><given-names>Z</given-names></name><name><surname>Takei</surname><given-names>M</given-names></name><name><surname>Endo</surname><given-names>K</given-names></name><name><surname>Hashimoto</surname><given-names>T</given-names></name><name><surname>Sakiya</surname><given-names>Y</given-names></name><etal/></person-group>
<year>1994</year>
<article-title>Marchantin A trimethyl ether: its molecular structure and tubocurarine-like skeletal muscle relaxation activity.</article-title>
<source>Chem Pharm Bull</source>
<volume>42</volume>
<fpage>52</fpage>
<lpage>56</lpage>
<pub-id pub-id-type="pmid">8124766</pub-id></element-citation></ref><ref id="pone.0019825-Harinantenaina1"><label>28</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Harinantenaina</surname><given-names>L</given-names></name><name><surname>Quang</surname><given-names>DN</given-names></name><name><surname>Takeshi</surname><given-names>N</given-names></name><name><surname>Hashimoto</surname><given-names>T</given-names></name><name><surname>Kohchi</surname><given-names>C</given-names></name><etal/></person-group>
<year>2005</year>
<article-title>Bis(bibenzyls) from liverworts inhibit lipopolysaccharide-induced inducible NOS in RAW 264.7 cells: a study of structure-activity relationships and molecular mechanism.</article-title>
<source>J Nat Prod</source>
<volume>68</volume>
<fpage>1779</fpage>
<lpage>1781</lpage>
<pub-id pub-id-type="pmid">16378374</pub-id></element-citation></ref><ref id="pone.0019825-Iwai1"><label>29</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Iwai</surname><given-names>Y</given-names></name><name><surname>Takahashi</surname><given-names>H</given-names></name><name><surname>Hatakeyama</surname><given-names>D</given-names></name><name><surname>Motoshima</surname><given-names>K</given-names></name><name><surname>Ishikawa</surname><given-names>M</given-names></name><etal/></person-group>
<year>2010</year>
<article-title>Anti-influenza activity of phenethylphenylphthalimide analogs derived from thalidomide.</article-title>
<source>Bioorg Med Chem</source>
<volume>18</volume>
<fpage>5379</fpage>
<lpage>5390</lpage>
<pub-id pub-id-type="pmid">20538468</pub-id></element-citation></ref><ref id="pone.0019825-Zhao1"><label>30</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhao</surname><given-names>C</given-names></name><name><surname>Lou</surname><given-names>Z</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Ma</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><etal/></person-group>
<year>2009</year>
<article-title>Nucleoside monophosphate complex structures of the endonuclease domain from the influenza virus polymerase PA subunit reveal the substrate binding site inside the catalytic center.</article-title>
<source>J Virol</source>
<volume>83</volume>
<fpage>9024</fpage>
<lpage>9030</lpage>
<pub-id pub-id-type="pmid">19587036</pub-id></element-citation></ref><ref id="pone.0019825-Morris1"><label>31</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Morris</surname><given-names>GM</given-names></name><name><surname>Goodsell</surname><given-names>DS</given-names></name><name><surname>Halliday</surname><given-names>RS</given-names></name><name><surname>Huey</surname></name><name><surname>R</surname></name><name><surname>Hart</surname><given-names>WE</given-names></name><etal/></person-group>
<year>1998</year>
<article-title>Automated docking using Lamarckian genetic algorithm and an empirical binding free energy function.</article-title>
<source>J Comp Chem</source>
<volume>19</volume>
<fpage>1639</fpage>
<lpage>1662</lpage>
</element-citation></ref><ref id="pone.0019825-Chemical1"><label>32</label><element-citation publication-type="journal">
<collab>Chemical Computing Group C.Molecular Operative Environment (MOE)</collab>
<year>2004</year>
<comment>0707</comment>
</element-citation></ref><ref id="pone.0019825-Goto1"><label>33</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Goto</surname><given-names>J</given-names></name><name><surname>Kataoka</surname><given-names>R</given-names></name></person-group>
<year>2008</year>
<article-title>ASEDock-Docking Based on Alpha Spheres and Excluded Volumes.</article-title>
<source>J Chem Inf Model</source>
<volume>48</volume>
<fpage>583</fpage>
<lpage>590</lpage>
<pub-id pub-id-type="pmid">18278891</pub-id></element-citation></ref><ref id="pone.0019825-Taub1"><label>34</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Taub</surname><given-names>M</given-names></name><name><surname>Saier</surname><given-names>MH</given-names><suffix>Jr</suffix></name></person-group>
<year>1979</year>
<article-title>An established but differentiated kidney epithelial cell line (MDCK).</article-title>
<source>Methods Enzymol</source>
<volume>58</volume>
<fpage>552</fpage>
<lpage>560</lpage>
<pub-id pub-id-type="pmid">218080</pub-id></element-citation></ref><ref id="pone.0019825-Virology1"><label>35</label><element-citation publication-type="journal">
<person-group person-group-type="editor"><name><surname>Mahy</surname><given-names>BWJ</given-names></name><name><surname>Kangro</surname><given-names>HO</given-names></name></person-group>
<article-title>Virology Methods Manual.</article-title>
<source>Academic Press Limited</source>
<fpage>35</fpage>
<lpage>37</lpage>
</element-citation></ref><ref id="pone.0019825-Okuno1"><label>36</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Okuno</surname><given-names>Y</given-names></name><name><surname>Tanaka</surname><given-names>K</given-names></name><name><surname>Baba</surname><given-names>K</given-names></name><name><surname>Maeda</surname><given-names>A</given-names></name><name><surname>Kunita</surname><given-names>N</given-names></name><etal/></person-group>
<year>1990</year>
<article-title>Rapid focus reduction neutralization test of influenza A and B viruses in microtiter system.</article-title>
<source>J Clin Microbiol</source>
<volume>28</volume>
<fpage>1308</fpage>
<lpage>1313</lpage>
<pub-id pub-id-type="pmid">2380359</pub-id></element-citation></ref><ref id="pone.0019825-Thompson1"><label>37</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Thompson</surname><given-names>JD</given-names></name><name><surname>Gibson</surname><given-names>TJ</given-names></name><name><surname>Plewniak</surname><given-names>F</given-names></name><name><surname>Jeanmougin</surname><given-names>F</given-names></name><name><surname>Higgins</surname><given-names>DG</given-names></name></person-group>
<year>1997</year>
<article-title>The ClustalX windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools.</article-title>
<source>Nucleic Acids Research</source>
<volume>24</volume>
<fpage>4876</fpage>
<lpage>4882</lpage>
</element-citation></ref><ref id="pone.0019825-Yang1"><label>38</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yang</surname><given-names>CS</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Lu</surname><given-names>G</given-names></name><name><surname>Picinich</surname><given-names>SC</given-names></name></person-group>
<year>2009</year>
<article-title>Cancer prevention by tea: animal studies, molecular mechanisms and human relevance.</article-title>
<source>Nat Rev Cancer</source>
<volume>9</volume>
<fpage>429</fpage>
<lpage>439</lpage>
<pub-id pub-id-type="pmid">19472429</pub-id></element-citation></ref><ref id="pone.0019825-Song1"><label>39</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Song</surname><given-names>JM</given-names></name><name><surname>Lee</surname><given-names>KH</given-names></name><name><surname>Seong</surname><given-names>BL</given-names></name></person-group>
<year>2005</year>
<article-title>Antiviral effect of catechins in green tea on influenza virus.</article-title>
<source>Antiviral Res</source>
<volume>68</volume>
<fpage>66</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="pmid">16137775</pub-id></element-citation></ref><ref id="pone.0019825-Hashimoto1"><label>40</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hashimoto</surname><given-names>T</given-names></name><name><surname>Tahara</surname><given-names>S</given-names></name><name><surname>Takaoka</surname><given-names>S</given-names></name><name><surname>Tori</surname><given-names>M</given-names></name><name><surname>Asakawa</surname><given-names>Y</given-names></name></person-group>
<year>1994</year>
<article-title>Structures of daldinins A-C, three novel azaphylone derivatives from the fungus <italic>Daldinia concentrica</italic>.</article-title>
<source>Chem Pharm Bull</source>
<volume>42</volume>
<fpage>2397</fpage>
<lpage>2399</lpage>
</element-citation></ref><ref id="pone.0019825-Hashimoto2"><label>41</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hashimoto</surname><given-names>T</given-names></name><name><surname>Tahara</surname><given-names>S</given-names></name><name><surname>Takaoka</surname><given-names>S</given-names></name><name><surname>Tori</surname><given-names>M</given-names></name><name><surname>Asakawa</surname><given-names>Y</given-names></name></person-group>
<year>1994</year>
<article-title>Structures of a novel binaphthyl and three novel benzophenone derivatives with plant-growth inhibitory activity from the fungus <italic>Daldinia concentric</italic>.</article-title>
<source>Chem Pharm Bull</source>
<volume>42</volume>
<fpage>1376</fpage>
<lpage>1378</lpage>
</element-citation></ref><ref id="pone.0019825-Hashimoto3"><label>42</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hashimoto</surname><given-names>T</given-names></name><name><surname>Asakawa</surname><given-names>Y</given-names></name><name><surname>Fujiki</surname><given-names>H</given-names></name><name><surname>Suganuma</surname><given-names>M</given-names></name><name><surname>Yamada</surname><given-names>S</given-names></name><etal/></person-group>
<year>2003</year>
<article-title>Isolation and synthesis of TNF-&#x003b1; release inhibitors from Fijian Kawa (<italic>Piper methysticum</italic>).</article-title>
<source>Phytomedicine</source>
<volume>10</volume>
<fpage>309</fpage>
<lpage>317</lpage>
<pub-id pub-id-type="pmid">12809361</pub-id></element-citation></ref><ref id="pone.0019825-Buchanan1"><label>43</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Buchanan</surname><given-names>MS</given-names></name><name><surname>Hashimoto</surname></name><name><surname>T</surname></name><name><surname>Takaoka</surname><given-names>S</given-names></name><name><surname>Asakawa</surname><given-names>Y</given-names></name></person-group>
<year>1995</year>
<article-title>(&#x0002b;)-Osmun dalactone, &#x003b3;-lactones and spiromentins spiromentins from the fungus <italic>Paxillus atromentosus</italic>, Phytochemistry</article-title>
<volume>40</volume>
<fpage>1251</fpage>
<lpage>1257</lpage>
</element-citation></ref><ref id="pone.0019825-Hashimoto4"><label>44</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hashimoto</surname><given-names>T</given-names></name><name><surname>Yasuda</surname><given-names>A</given-names></name><name><surname>Akazawa</surname><given-names>K</given-names></name><name><surname>Takaoka</surname><given-names>S</given-names></name><name><surname>Tori</surname><given-names>M</given-names></name><etal/></person-group>
<year>1994</year>
<article-title>Three novel dimetyl pyrrole-dicarboxylate, lycogarubins A-C, from the Myxomycetes <italic>Lycogala epidendrum</italic>.</article-title>
<source>Tetrahedron Letters</source>
<volume>35</volume>
<fpage>2559</fpage>
<lpage>2560</lpage>
</element-citation></ref><ref id="pone.0019825-Nakamura1"><label>45</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>Y</given-names></name><name><surname>Oda</surname><given-names>K</given-names></name><name><surname>Nakada</surname><given-names>S</given-names></name></person-group>
<year>1991</year>
<article-title>Growth complementation of influenza virus temperature-sensitive mutants in mouse cells which express the RNA polymerase and nucleoprotein genes.</article-title>
<source>J Biochem</source>
<volume>110</volume>
<fpage>395</fpage>
<lpage>401</lpage>
<pub-id pub-id-type="pmid">1663110</pub-id></element-citation></ref><ref id="pone.0019825-Mullis1"><label>46</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mullis</surname><given-names>KB</given-names></name><name><surname>Faloona</surname><given-names>FA</given-names></name></person-group>
<year>1987</year>
<article-title>Specific synthesis of DNA <italic>in vitro</italic> via a polymerase-catalyzed chain reaction.</article-title>
<source>Methods Enzymol</source>
<volume>155</volume>
<fpage>335</fpage>
<lpage>350</lpage>
<pub-id pub-id-type="pmid">3431465</pub-id></element-citation></ref><ref id="pone.0019825-Studier1"><label>47</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Studier</surname><given-names>FW</given-names></name><name><surname>Moffatt</surname><given-names>BA</given-names></name></person-group>
<year>1986</year>
<article-title>Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes.</article-title>
<source>J Mol Biol</source>
<volume>189</volume>
<fpage>113</fpage>
<lpage>130</lpage>
<pub-id pub-id-type="pmid">3537305</pub-id></element-citation></ref><ref id="pone.0019825-Janknecht1"><label>48</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Janknecht</surname><given-names>R</given-names></name><name><surname>de Martynoff</surname><given-names>G</given-names></name><name><surname>Lou</surname><given-names>J</given-names></name><name><surname>Hipskind</surname><given-names>RA</given-names></name><name><surname>Nordheim</surname><given-names>A</given-names></name><etal/></person-group>
<year>1991</year>
<article-title>Rapid and efficient purification of native histidine-tagged protein expressed by recombinant vaccinia virus.</article-title>
<source>Proc Natl Acad Sci USA</source>
<volume>88</volume>
<fpage>8972</fpage>
<lpage>8976</lpage>
<pub-id pub-id-type="pmid">1924358</pub-id></element-citation></ref></ref-list></back></article>